Literature DB >> 7639483

Transposition of the greater omentum for recalcitrant median sternotomy wound infections.

N Weinzweig1, R Yetman.   

Abstract

During a 3-year period, 25 patients underwent transposition of the greater omentum, either alone or in combination with muscle flaps, for treatment of recalcitrant median sternotomy wound infections. Most patients underwent radical sternectomy for deep and extensive sternal wounds; the others had significant defects involving the lower third of the sternum. The most common combination of flaps was omentum and bilateral pectoralis major musculocutaneous flaps (14 patients). Delay to reconstruction after the recognition of median sternotomy infection ranged from 2 to 36 days (average, 13.9 days) except for one patient treated outside by the "open method" for 18 months. Definitive closure was performed after an average of 1.8 debridements (range, 1-4). Hospitalization averaged 28.5 days (range, 13-42 days) in 16 of the 19 surviving patients. The majority of these patients had far more extensive sternal defects than those usually treated by muscle flaps alone. Healing was ultimately achieved in 95% of infected sternotomy wounds. Seventy-four percent of patients healed their sternal wounds uneventfully without subsequent problems. Flap site complications in the remaining patients included recurrent chondritis (16%) and partial (4%) or complete (4%) flap loss. Donor-site complications included abdominal wall herniation (21%), hematoma (8%), and seroma (4%). There were no problems with chest wall instability or intra-abdominal morbidity. Six patients (24%) succumbed to multisystem failure unrelated to sternal infection. We present our experience--including indications, technique, and outcome--with transposition of the greater omentum for recalcitrant median sternotomy wound infections.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7639483     DOI: 10.1097/00000637-199505000-00004

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  7 in total

1.  Topical versus systemic vancomycin for deep sternal wound infection caused by methicillin-resistant Staphylococcus aureus in a rodent experimental model.

Authors:  Ali V Ozcan; Melek Demir; Gokhan Onem; Ibrahim Goksin; Ahmet Baltalarli; Veli K Topkara; Ilknur Kaleli
Journal:  Tex Heart Inst J       Date:  2006

2.  Utility of the omentum in the reconstruction of complex extraperitoneal wounds and defects: donor-site complications in 135 patients from 1975 to 2000.

Authors:  C Scott Hultman; Grant W Carlson; Albert Losken; Glyn Jones; John Culbertson; Gregory Mackay; John Bostwick; M J Jurkiewicz
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

3.  Reconstruction of the abdominal wall by using a combination of the human acellular dermal matrix implant and an interpositional omentum flap after extensive tumor resection in patients with abdominal wall neoplasm: a preliminary result.

Authors:  Yan Gu; Rui Tang; Ding-Quan Gong; Yun-Liang Qian
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  [Sternal osteomyelitis - Surgical treatment concepts].

Authors:  J P Beier; A Arkudas; W Lang; M Weyand; R E Horch
Journal:  Chirurg       Date:  2016-06       Impact factor: 0.955

5.  Chronic encapsulated mediastinal abscess presenting with remote cutaneous fistulization 12 years after redo aortic valve replacement for prosthetic valve endocarditis.

Authors:  Pankaj Kaul; Syed S A Qadri; Mohd Riaz
Journal:  J Cardiothorac Surg       Date:  2006-08-24       Impact factor: 1.637

6.  Minimally invasive mitral valve surgery: a systematic review.

Authors:  Fabiana Lucà; Leen van Garsse; Carmelo Massimiliano Rao; Orlando Parise; Mark La Meir; Calogero Puntrello; Gaspare Rubino; Rocco Carella; Roberto Lorusso; Gian Franco Gensini; Jos G Maessen; Sandro Gelsomino
Journal:  Minim Invasive Surg       Date:  2013-03-27

7.  Omentum flap as a salvage procedure in deep sternal wound infection.

Authors:  Nick Spindler; Christian D Etz; Martin Misfeld; Christoph Josten; Friedrich-Wilhelm Mohr; Stefan Langer
Journal:  Ther Clin Risk Manag       Date:  2017-08-23       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.